ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.

February 25, 2000

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001